12D miR HR13_24
Name | miRBASE accession |
---|---|
mmu-miR-200b-3p
|
MIMAT0000233 |
mmu-miR-200c-3p
|
MIMAT0000657 |
mmu-miR-429-3p
|
MIMAT0001537 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_36868467 | 3.99 |
ENSMUST00000031003.7
|
Ppp2r2c
|
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform |
chr9_-_22389113 | 3.19 |
ENSMUST00000040912.7
|
Anln
|
anillin, actin binding protein |
chr13_+_108316332 | 3.19 |
ENSMUST00000051594.5
|
Depdc1b
|
DEP domain containing 1B |
chr18_+_22345089 | 3.14 |
ENSMUST00000120223.1
ENSMUST00000097655.3 |
Asxl3
|
additional sex combs like 3 (Drosophila) |
chr11_-_87108656 | 2.89 |
ENSMUST00000051395.8
|
Prr11
|
proline rich 11 |
chr2_+_31245801 | 2.89 |
ENSMUST00000000199.7
|
Ncs1
|
neuronal calcium sensor 1 |
chr8_-_31918203 | 2.75 |
ENSMUST00000073884.4
|
Nrg1
|
neuregulin 1 |
chr1_+_55406163 | 2.60 |
ENSMUST00000042986.8
|
Plcl1
|
phospholipase C-like 1 |
chr12_-_108003594 | 2.38 |
ENSMUST00000066060.4
|
Bcl11b
|
B cell leukemia/lymphoma 11B |
chr6_+_120666388 | 2.14 |
ENSMUST00000112686.1
|
Cecr2
|
cat eye syndrome chromosome region, candidate 2 |
chr4_+_17853451 | 2.13 |
ENSMUST00000029881.3
|
Mmp16
|
matrix metallopeptidase 16 |
chr5_-_142608785 | 2.07 |
ENSMUST00000037048.7
|
Mmd2
|
monocyte to macrophage differentiation-associated 2 |
chr1_+_158362261 | 2.02 |
ENSMUST00000046110.9
|
Astn1
|
astrotactin 1 |
chr11_-_90390895 | 1.99 |
ENSMUST00000004051.7
|
Hlf
|
hepatic leukemia factor |
chr4_-_91372028 | 1.84 |
ENSMUST00000107110.1
ENSMUST00000008633.8 ENSMUST00000107118.1 |
Elavl2
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) |
chr1_+_34801704 | 1.79 |
ENSMUST00000047664.9
|
Arhgef4
|
Rho guanine nucleotide exchange factor (GEF) 4 |
chr18_+_5591860 | 1.78 |
ENSMUST00000025081.5
ENSMUST00000159390.1 |
Zeb1
|
zinc finger E-box binding homeobox 1 |
chr12_-_112929415 | 1.75 |
ENSMUST00000075827.3
|
Jag2
|
jagged 2 |
chr6_+_71707561 | 1.74 |
ENSMUST00000121469.1
|
Reep1
|
receptor accessory protein 1 |
chr11_-_118909487 | 1.69 |
ENSMUST00000117731.1
ENSMUST00000106278.2 ENSMUST00000120061.1 ENSMUST00000017576.4 |
Rbfox3
|
RNA binding protein, fox-1 homolog (C. elegans) 3 |
chr2_-_51149100 | 1.68 |
ENSMUST00000154545.1
ENSMUST00000017288.2 |
Rnd3
|
Rho family GTPase 3 |
chr10_+_41810528 | 1.67 |
ENSMUST00000099931.3
|
Sesn1
|
sestrin 1 |
chr8_+_123411424 | 1.66 |
ENSMUST00000071134.3
|
Tubb3
|
tubulin, beta 3 class III |
chr4_-_132732514 | 1.66 |
ENSMUST00000045550.4
|
Xkr8
|
X Kell blood group precursor related family member 8 homolog |
chr10_+_110920170 | 1.65 |
ENSMUST00000020403.5
|
Csrp2
|
cysteine and glycine-rich protein 2 |
chr2_-_42653598 | 1.61 |
ENSMUST00000052550.6
|
Lrp1b
|
low density lipoprotein-related protein 1B (deleted in tumors) |
chr15_-_64312636 | 1.59 |
ENSMUST00000177083.1
ENSMUST00000177371.1 |
Asap1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
chr11_-_119547744 | 1.57 |
ENSMUST00000026670.4
|
Nptx1
|
neuronal pentraxin 1 |
chr16_+_16896469 | 1.54 |
ENSMUST00000027373.9
|
Ppm1f
|
protein phosphatase 1F (PP2C domain containing) |
chr1_-_153332724 | 1.54 |
ENSMUST00000027752.8
|
Lamc1
|
laminin, gamma 1 |
chr1_-_9700209 | 1.52 |
ENSMUST00000088658.4
|
Mybl1
|
myeloblastosis oncogene-like 1 |
chr12_-_73047179 | 1.50 |
ENSMUST00000050029.7
|
Six1
|
sine oculis-related homeobox 1 |
chr17_-_35838259 | 1.49 |
ENSMUST00000001566.8
|
Tubb5
|
tubulin, beta 5 class I |
chr7_+_18925863 | 1.48 |
ENSMUST00000172835.1
ENSMUST00000032571.8 |
Nova2
|
neuro-oncological ventral antigen 2 |
chr13_-_55329723 | 1.46 |
ENSMUST00000021941.7
|
Mxd3
|
Max dimerization protein 3 |
chr16_+_21891969 | 1.44 |
ENSMUST00000042065.6
|
Map3k13
|
mitogen-activated protein kinase kinase kinase 13 |
chr5_-_20882072 | 1.43 |
ENSMUST00000118174.1
|
Phtf2
|
putative homeodomain transcription factor 2 |
chr6_+_8948608 | 1.35 |
ENSMUST00000160300.1
|
Nxph1
|
neurexophilin 1 |
chr9_-_16378231 | 1.34 |
ENSMUST00000082170.5
|
Fat3
|
FAT tumor suppressor homolog 3 (Drosophila) |
chr10_+_103367748 | 1.33 |
ENSMUST00000074204.4
ENSMUST00000179636.1 |
Slc6a15
|
solute carrier family 6 (neurotransmitter transporter), member 15 |
chr12_-_98737405 | 1.33 |
ENSMUST00000170188.1
|
Ptpn21
|
protein tyrosine phosphatase, non-receptor type 21 |
chr12_+_78861693 | 1.33 |
ENSMUST00000071230.7
|
Eif2s1
|
eukaryotic translation initiation factor 2, subunit 1 alpha |
chr2_+_181763315 | 1.31 |
ENSMUST00000081125.4
|
Myt1
|
myelin transcription factor 1 |
chr2_+_102658640 | 1.29 |
ENSMUST00000080210.3
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr1_+_187997821 | 1.29 |
ENSMUST00000027906.6
|
Esrrg
|
estrogen-related receptor gamma |
chrX_+_71555918 | 1.27 |
ENSMUST00000072699.6
ENSMUST00000114582.2 ENSMUST00000015361.4 ENSMUST00000088874.3 |
Hmgb3
|
high mobility group box 3 |
chr5_+_146384947 | 1.15 |
ENSMUST00000110600.1
ENSMUST00000016143.7 |
Wasf3
|
WAS protein family, member 3 |
chr2_-_73529725 | 1.12 |
ENSMUST00000094681.4
|
Wipf1
|
WAS/WASL interacting protein family, member 1 |
chr18_+_10325148 | 1.12 |
ENSMUST00000048977.8
|
Greb1l
|
growth regulation by estrogen in breast cancer-like |
chr3_-_53657339 | 1.09 |
ENSMUST00000091137.4
|
Frem2
|
Fras1 related extracellular matrix protein 2 |
chr16_+_14705832 | 1.07 |
ENSMUST00000023356.6
|
Snai2
|
snail homolog 2 (Drosophila) |
chr15_-_73184840 | 1.05 |
ENSMUST00000044113.10
|
Ago2
|
argonaute RISC catalytic subunit 2 |
chr9_+_72532214 | 1.05 |
ENSMUST00000163401.2
ENSMUST00000093820.3 |
Rfx7
|
regulatory factor X, 7 |
chr3_-_152982240 | 1.04 |
ENSMUST00000044278.5
|
St6galnac5
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
chr17_+_42315947 | 1.04 |
ENSMUST00000048691.4
|
Ptchd4
|
patched domain containing 4 |
chr12_+_40446050 | 1.03 |
ENSMUST00000037488.6
|
Dock4
|
dedicator of cytokinesis 4 |
chr12_-_5375682 | 1.03 |
ENSMUST00000020958.8
|
Klhl29
|
kelch-like 29 |
chr2_-_45113255 | 1.01 |
ENSMUST00000068415.4
ENSMUST00000127520.1 |
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr17_-_31658729 | 0.98 |
ENSMUST00000166526.1
ENSMUST00000014684.4 |
U2af1
|
U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 1 |
chrX_-_75875101 | 0.94 |
ENSMUST00000114059.3
|
Pls3
|
plastin 3 (T-isoform) |
chr3_+_68468162 | 0.94 |
ENSMUST00000182532.1
|
Schip1
|
schwannomin interacting protein 1 |
chr1_-_38129618 | 0.90 |
ENSMUST00000027251.6
|
Rev1
|
REV1 homolog (S. cerevisiae) |
chr1_+_171370345 | 0.89 |
ENSMUST00000006578.3
ENSMUST00000094325.4 |
Pvrl4
|
poliovirus receptor-related 4 |
chr14_+_70077375 | 0.89 |
ENSMUST00000035908.1
|
Egr3
|
early growth response 3 |
chr2_+_3713449 | 0.87 |
ENSMUST00000027965.4
|
Fam107b
|
family with sequence similarity 107, member B |
chr16_-_58523349 | 0.84 |
ENSMUST00000137035.1
|
St3gal6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
chr9_+_72806874 | 0.84 |
ENSMUST00000055535.8
|
Prtg
|
protogenin homolog (Gallus gallus) |
chr11_+_77216180 | 0.84 |
ENSMUST00000037912.5
ENSMUST00000156488.1 |
Ssh2
|
slingshot homolog 2 (Drosophila) |
chr7_+_102702331 | 0.83 |
ENSMUST00000094124.3
|
Olfr558
|
olfactory receptor 558 |
chr2_+_124610573 | 0.83 |
ENSMUST00000103239.3
ENSMUST00000103240.2 |
Sema6d
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
chr13_-_47106176 | 0.82 |
ENSMUST00000021807.6
ENSMUST00000135278.1 |
Dek
|
DEK oncogene (DNA binding) |
chr12_-_30911593 | 0.82 |
ENSMUST00000062740.7
ENSMUST00000074038.5 |
Acp1
|
acid phosphatase 1, soluble |
chr2_+_65620829 | 0.81 |
ENSMUST00000028377.7
|
Scn2a1
|
sodium channel, voltage-gated, type II, alpha 1 |
chr3_+_7366598 | 0.81 |
ENSMUST00000028999.6
|
Pkia
|
protein kinase inhibitor, alpha |
chr11_-_97744659 | 0.81 |
ENSMUST00000018691.8
|
Pip4k2b
|
phosphatidylinositol-5-phosphate 4-kinase, type II, beta |
chr13_-_40733768 | 0.81 |
ENSMUST00000110193.2
|
Tfap2a
|
transcription factor AP-2, alpha |
chr9_+_51765325 | 0.80 |
ENSMUST00000065496.5
|
Arhgap20
|
Rho GTPase activating protein 20 |
chr14_+_101729907 | 0.80 |
ENSMUST00000100337.3
|
Lmo7
|
LIM domain only 7 |
chr10_-_92722356 | 0.79 |
ENSMUST00000020163.6
|
Nedd1
|
neural precursor cell expressed, developmentally down-regulated gene 1 |
chr18_+_69345721 | 0.79 |
ENSMUST00000078486.6
ENSMUST00000114982.1 |
Tcf4
|
transcription factor 4 |
chr1_-_178337774 | 0.79 |
ENSMUST00000037748.7
|
Hnrnpu
|
heterogeneous nuclear ribonucleoprotein U |
chr13_+_16014457 | 0.79 |
ENSMUST00000164993.1
|
Inhba
|
inhibin beta-A |
chr19_+_60755947 | 0.77 |
ENSMUST00000088237.4
|
Nanos1
|
nanos homolog 1 (Drosophila) |
chr1_+_15712303 | 0.77 |
ENSMUST00000170146.1
|
Kcnb2
|
potassium voltage gated channel, Shab-related subfamily, member 2 |
chr5_-_114773488 | 0.76 |
ENSMUST00000178440.1
ENSMUST00000043283.7 ENSMUST00000112185.2 |
Git2
|
G protein-coupled receptor kinase-interactor 2 |
chrX_-_152368680 | 0.76 |
ENSMUST00000070316.5
|
Gpr173
|
G-protein coupled receptor 173 |
chr3_+_101377074 | 0.75 |
ENSMUST00000043983.5
|
Igsf3
|
immunoglobulin superfamily, member 3 |
chr10_+_80755196 | 0.74 |
ENSMUST00000105336.2
|
Dot1l
|
DOT1-like, histone H3 methyltransferase (S. cerevisiae) |
chr13_+_54071815 | 0.74 |
ENSMUST00000021930.8
|
Sfxn1
|
sideroflexin 1 |
chr19_-_41802028 | 0.73 |
ENSMUST00000026150.8
ENSMUST00000177495.1 ENSMUST00000163265.1 |
Arhgap19
|
Rho GTPase activating protein 19 |
chr13_-_58113592 | 0.71 |
ENSMUST00000160860.1
|
Klhl3
|
kelch-like 3 |
chr11_-_106612928 | 0.71 |
ENSMUST00000042780.7
|
Tex2
|
testis expressed gene 2 |
chr10_+_40883819 | 0.71 |
ENSMUST00000105509.1
|
Wasf1
|
WAS protein family, member 1 |
chr5_-_135934590 | 0.71 |
ENSMUST00000055808.5
|
Ywhag
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
chr2_+_153741274 | 0.69 |
ENSMUST00000028981.8
|
Mapre1
|
microtubule-associated protein, RP/EB family, member 1 |
chr14_-_98169542 | 0.69 |
ENSMUST00000069334.7
ENSMUST00000071533.6 |
Dach1
|
dachshund 1 (Drosophila) |
chr8_-_116732991 | 0.69 |
ENSMUST00000109102.2
|
Cdyl2
|
chromodomain protein, Y chromosome-like 2 |
chr9_-_114564315 | 0.68 |
ENSMUST00000111816.2
|
Trim71
|
tripartite motif-containing 71 |
chr4_-_129189512 | 0.68 |
ENSMUST00000117965.1
ENSMUST00000106061.2 ENSMUST00000072431.6 |
S100pbp
|
S100P binding protein |
chr2_+_119897212 | 0.67 |
ENSMUST00000046717.6
ENSMUST00000110774.1 ENSMUST00000110773.2 ENSMUST00000079934.5 ENSMUST00000156510.1 |
Mga
|
MAX gene associated |
chr1_-_106714217 | 0.67 |
ENSMUST00000112751.1
|
Bcl2
|
B cell leukemia/lymphoma 2 |
chr14_-_79771305 | 0.67 |
ENSMUST00000039568.5
|
Pcdh8
|
protocadherin 8 |
chr4_+_57637816 | 0.67 |
ENSMUST00000150412.1
|
Gm20459
|
predicted gene 20459 |
chr4_-_41569502 | 0.67 |
ENSMUST00000108049.2
ENSMUST00000108052.3 ENSMUST00000108050.1 |
Fam219a
|
family with sequence similarity 219, member A |
chr1_-_152766281 | 0.66 |
ENSMUST00000111859.1
ENSMUST00000148865.1 |
Rgl1
|
ral guanine nucleotide dissociation stimulator,-like 1 |
chr14_-_31830402 | 0.65 |
ENSMUST00000014640.7
|
Ankrd28
|
ankyrin repeat domain 28 |
chr2_+_90745370 | 0.64 |
ENSMUST00000013759.5
|
Fnbp4
|
formin binding protein 4 |
chr13_+_35659856 | 0.64 |
ENSMUST00000075220.6
|
Cdyl
|
chromodomain protein, Y chromosome-like |
chr1_+_37997975 | 0.63 |
ENSMUST00000027252.7
|
Eif5b
|
eukaryotic translation initiation factor 5B |
chr2_-_65567465 | 0.63 |
ENSMUST00000066432.5
|
Scn3a
|
sodium channel, voltage-gated, type III, alpha |
chr13_+_41249841 | 0.62 |
ENSMUST00000165561.2
|
Smim13
|
small integral membrane protein 13 |
chr8_-_35495487 | 0.62 |
ENSMUST00000033927.6
|
Eri1
|
exoribonuclease 1 |
chr3_+_22076644 | 0.62 |
ENSMUST00000063988.8
|
Tbl1xr1
|
transducin (beta)-like 1X-linked receptor 1 |
chr10_-_71285234 | 0.61 |
ENSMUST00000020085.6
|
Ube2d1
|
ubiquitin-conjugating enzyme E2D 1 |
chr11_-_76846968 | 0.60 |
ENSMUST00000021201.5
|
Cpd
|
carboxypeptidase D |
chr9_-_32541589 | 0.59 |
ENSMUST00000016231.7
|
Fli1
|
Friend leukemia integration 1 |
chr3_+_88532314 | 0.58 |
ENSMUST00000172699.1
|
Mex3a
|
mex3 homolog A (C. elegans) |
chr16_-_76373827 | 0.58 |
ENSMUST00000121927.1
|
Nrip1
|
nuclear receptor interacting protein 1 |
chr6_-_143947092 | 0.58 |
ENSMUST00000144289.1
ENSMUST00000111748.1 |
Sox5
|
SRY-box containing gene 5 |
chr5_+_123076275 | 0.58 |
ENSMUST00000067505.8
ENSMUST00000111619.3 ENSMUST00000160344.1 |
Tmem120b
|
transmembrane protein 120B |
chr3_-_144570136 | 0.58 |
ENSMUST00000043325.7
|
Hs2st1
|
heparan sulfate 2-O-sulfotransferase 1 |
chr6_-_90810118 | 0.58 |
ENSMUST00000101151.3
|
Iqsec1
|
IQ motif and Sec7 domain 1 |
chr5_-_99978914 | 0.57 |
ENSMUST00000112939.3
ENSMUST00000171786.1 ENSMUST00000072750.6 ENSMUST00000019128.8 ENSMUST00000172361.1 |
Hnrnpd
|
heterogeneous nuclear ribonucleoprotein D |
chr4_+_11156411 | 0.56 |
ENSMUST00000029865.3
|
Trp53inp1
|
transformation related protein 53 inducible nuclear protein 1 |
chr7_+_82867327 | 0.55 |
ENSMUST00000082237.5
|
Mex3b
|
mex3 homolog B (C. elegans) |
chr17_+_15499888 | 0.55 |
ENSMUST00000159197.1
ENSMUST00000162505.1 ENSMUST00000014911.5 ENSMUST00000147081.2 ENSMUST00000118001.1 ENSMUST00000143924.1 ENSMUST00000119879.2 ENSMUST00000155051.1 ENSMUST00000117593.1 |
Tbp
|
TATA box binding protein |
chr4_-_34882919 | 0.54 |
ENSMUST00000098163.2
ENSMUST00000047950.5 |
Zfp292
|
zinc finger protein 292 |
chr11_-_102819114 | 0.54 |
ENSMUST00000068933.5
|
Gjc1
|
gap junction protein, gamma 1 |
chrX_-_111463043 | 0.54 |
ENSMUST00000065976.5
|
Rps6ka6
|
ribosomal protein S6 kinase polypeptide 6 |
chr9_+_40269430 | 0.54 |
ENSMUST00000171835.2
|
Scn3b
|
sodium channel, voltage-gated, type III, beta |
chr18_-_78123324 | 0.53 |
ENSMUST00000160292.1
ENSMUST00000091813.5 |
Slc14a1
|
solute carrier family 14 (urea transporter), member 1 |
chr12_-_13249198 | 0.53 |
ENSMUST00000071103.8
|
Ddx1
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 |
chr3_+_53041517 | 0.52 |
ENSMUST00000059562.7
ENSMUST00000147139.1 |
Lhfp
|
lipoma HMGIC fusion partner |
chr5_-_113908685 | 0.52 |
ENSMUST00000004646.6
|
Coro1c
|
coronin, actin binding protein 1C |
chrX_+_159532674 | 0.51 |
ENSMUST00000057180.6
|
A830080D01Rik
|
RIKEN cDNA A830080D01 gene |
chr10_-_84533884 | 0.50 |
ENSMUST00000053871.3
|
Ckap4
|
cytoskeleton-associated protein 4 |
chr15_-_89315253 | 0.50 |
ENSMUST00000144585.2
ENSMUST00000123791.1 |
Sbf1
|
SET binding factor 1 |
chr9_+_47530173 | 0.50 |
ENSMUST00000114548.1
ENSMUST00000152459.1 ENSMUST00000143026.1 ENSMUST00000085909.2 ENSMUST00000114547.1 ENSMUST00000034581.3 |
Cadm1
|
cell adhesion molecule 1 |
chr11_-_49712674 | 0.50 |
ENSMUST00000020624.6
ENSMUST00000145353.1 |
Cnot6
|
CCR4-NOT transcription complex, subunit 6 |
chr12_-_54862783 | 0.49 |
ENSMUST00000078124.7
|
Cfl2
|
cofilin 2, muscle |
chr1_+_66175286 | 0.49 |
ENSMUST00000114017.1
ENSMUST00000114015.1 |
Map2
|
microtubule-associated protein 2 |
chr10_-_91082653 | 0.49 |
ENSMUST00000159110.1
|
Apaf1
|
apoptotic peptidase activating factor 1 |
chrX_+_94367147 | 0.49 |
ENSMUST00000113897.2
ENSMUST00000113896.1 ENSMUST00000113895.1 |
Apoo
|
apolipoprotein O |
chr8_-_102785093 | 0.49 |
ENSMUST00000075190.3
|
Cdh11
|
cadherin 11 |
chr2_-_136387929 | 0.48 |
ENSMUST00000035264.2
ENSMUST00000077200.3 |
Pak7
|
p21 protein (Cdc42/Rac)-activated kinase 7 |
chr5_+_108065742 | 0.48 |
ENSMUST00000081567.4
ENSMUST00000170319.1 ENSMUST00000112626.1 |
Mtf2
|
metal response element binding transcription factor 2 |
chr5_+_142960343 | 0.47 |
ENSMUST00000031565.8
|
Fscn1
|
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
chr5_+_147430407 | 0.47 |
ENSMUST00000176600.1
|
Pan3
|
PAN3 polyA specific ribonuclease subunit homolog (S. cerevisiae) |
chr14_+_63606491 | 0.47 |
ENSMUST00000119973.2
|
Xkr6
|
X Kell blood group precursor related family member 6 homolog |
chr14_+_45351473 | 0.47 |
ENSMUST00000111835.2
|
Styx
|
serine/threonine/tyrosine interaction protein |
chr9_+_65908967 | 0.47 |
ENSMUST00000034949.3
ENSMUST00000154589.1 |
Csnk1g1
|
casein kinase 1, gamma 1 |
chr15_-_38300693 | 0.47 |
ENSMUST00000074043.5
|
Klf10
|
Kruppel-like factor 10 |
chr18_+_65580230 | 0.47 |
ENSMUST00000049016.5
ENSMUST00000183236.1 |
Zfp532
|
zinc finger protein 532 |
chr13_-_100552442 | 0.46 |
ENSMUST00000159515.1
ENSMUST00000160859.1 ENSMUST00000069756.4 |
Ocln
|
occludin |
chr13_-_46727932 | 0.45 |
ENSMUST00000021803.9
|
Nup153
|
nucleoporin 153 |
chr10_-_80387642 | 0.45 |
ENSMUST00000062946.6
ENSMUST00000105350.1 |
Mex3d
|
mex3 homolog D (C. elegans) |
chr5_-_86172747 | 0.45 |
ENSMUST00000039373.7
|
Uba6
|
ubiquitin-like modifier activating enzyme 6 |
chr9_+_108692116 | 0.45 |
ENSMUST00000035220.6
|
Prkar2a
|
protein kinase, cAMP dependent regulatory, type II alpha |
chr2_-_148732457 | 0.45 |
ENSMUST00000028926.6
|
Napb
|
N-ethylmaleimide sensitive fusion protein attachment protein beta |
chr10_+_69533761 | 0.45 |
ENSMUST00000182884.1
|
Ank3
|
ankyrin 3, epithelial |
chr8_+_106210936 | 0.44 |
ENSMUST00000071592.5
|
Prmt7
|
protein arginine N-methyltransferase 7 |
chr17_-_31855782 | 0.44 |
ENSMUST00000024839.4
|
Sik1
|
salt inducible kinase 1 |
chr17_+_27856443 | 0.44 |
ENSMUST00000114849.1
|
Uhrf1bp1
|
UHRF1 (ICBP90) binding protein 1 |
chr3_+_90341654 | 0.44 |
ENSMUST00000049382.4
|
Gatad2b
|
GATA zinc finger domain containing 2B |
chr13_-_119790805 | 0.44 |
ENSMUST00000178271.1
ENSMUST00000177916.1 |
Zfp131
|
zinc finger protein 131 |
chr10_-_37138863 | 0.43 |
ENSMUST00000092584.5
|
Marcks
|
myristoylated alanine rich protein kinase C substrate |
chrX_+_163908982 | 0.43 |
ENSMUST00000069041.8
|
Ap1s2
|
adaptor-related protein complex 1, sigma 2 subunit |
chr5_-_89883321 | 0.43 |
ENSMUST00000163159.1
ENSMUST00000061427.5 |
Adamts3
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 |
chr5_+_65763518 | 0.43 |
ENSMUST00000113738.1
|
N4bp2
|
NEDD4 binding protein 2 |
chr15_+_80234071 | 0.42 |
ENSMUST00000023048.4
ENSMUST00000166030.1 |
Mief1
|
mitochondrial elongation factor 1 |
chr1_-_46854046 | 0.42 |
ENSMUST00000027131.4
|
Slc39a10
|
solute carrier family 39 (zinc transporter), member 10 |
chr11_+_76202007 | 0.42 |
ENSMUST00000094014.3
|
Fam57a
|
family with sequence similarity 57, member A |
chr17_+_34894515 | 0.42 |
ENSMUST00000052778.8
|
Zbtb12
|
zinc finger and BTB domain containing 12 |
chr3_-_51560816 | 0.41 |
ENSMUST00000037141.7
|
Setd7
|
SET domain containing (lysine methyltransferase) 7 |
chr2_+_163994960 | 0.41 |
ENSMUST00000018470.3
|
Ywhab
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide |
chr4_-_16163611 | 0.39 |
ENSMUST00000037035.5
|
Ripk2
|
receptor (TNFRSF)-interacting serine-threonine kinase 2 |
chr6_-_97617536 | 0.39 |
ENSMUST00000113355.2
|
Frmd4b
|
FERM domain containing 4B |
chr3_+_34649987 | 0.38 |
ENSMUST00000099151.2
|
Sox2
|
SRY-box containing gene 2 |
chr5_+_150673739 | 0.38 |
ENSMUST00000016569.4
ENSMUST00000038900.8 |
Pds5b
|
PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
chr1_-_136960427 | 0.38 |
ENSMUST00000027649.7
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr16_-_32003122 | 0.37 |
ENSMUST00000023457.5
|
Senp5
|
SUMO/sentrin specific peptidase 5 |
chr7_+_27591513 | 0.36 |
ENSMUST00000108344.2
|
Akt2
|
thymoma viral proto-oncogene 2 |
chr7_-_34313531 | 0.36 |
ENSMUST00000108074.1
|
4931406P16Rik
|
RIKEN cDNA 4931406P16 gene |
chr5_+_21737141 | 0.36 |
ENSMUST00000030882.5
|
Pmpcb
|
peptidase (mitochondrial processing) beta |
chr6_-_53068562 | 0.36 |
ENSMUST00000074541.5
|
Jazf1
|
JAZF zinc finger 1 |
chrX_-_103821940 | 0.36 |
ENSMUST00000042664.5
|
Slc16a2
|
solute carrier family 16 (monocarboxylic acid transporters), member 2 |
chr2_+_18677002 | 0.36 |
ENSMUST00000028071.6
|
Bmi1
|
Bmi1 polycomb ring finger oncogene |
chr12_-_59011996 | 0.36 |
ENSMUST00000021375.5
|
Sec23a
|
SEC23A (S. cerevisiae) |
chr2_-_125859139 | 0.36 |
ENSMUST00000110463.1
ENSMUST00000028635.5 |
Cops2
|
COP9 (constitutive photomorphogenic) homolog, subunit 2 (Arabidopsis thaliana) |
chr9_+_32696005 | 0.35 |
ENSMUST00000034534.6
ENSMUST00000050797.7 ENSMUST00000184887.1 |
Ets1
|
E26 avian leukemia oncogene 1, 5' domain |
chr16_+_20498817 | 0.35 |
ENSMUST00000003320.6
|
Eif2b5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon |
chr18_+_74065102 | 0.35 |
ENSMUST00000066583.1
|
Gm9925
|
predicted gene 9925 |
chr9_-_31211805 | 0.35 |
ENSMUST00000072634.7
ENSMUST00000079758.7 |
Aplp2
|
amyloid beta (A4) precursor-like protein 2 |
chr15_-_96699698 | 0.35 |
ENSMUST00000023099.6
|
Slc38a2
|
solute carrier family 38, member 2 |
chr16_-_59555752 | 0.35 |
ENSMUST00000179383.1
ENSMUST00000044604.8 |
Crybg3
|
beta-gamma crystallin domain containing 3 |
chr1_+_39900883 | 0.34 |
ENSMUST00000163854.2
ENSMUST00000168431.1 |
Map4k4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
chr9_+_78113275 | 0.34 |
ENSMUST00000009972.5
ENSMUST00000117330.1 ENSMUST00000044551.7 |
Ick
|
intestinal cell kinase |
chr1_+_62703285 | 0.33 |
ENSMUST00000102822.2
ENSMUST00000075144.5 |
Nrp2
|
neuropilin 2 |
chr5_+_142401484 | 0.33 |
ENSMUST00000072837.5
|
Foxk1
|
forkhead box K1 |
chr11_+_80209019 | 0.32 |
ENSMUST00000077451.7
ENSMUST00000055056.9 |
Rhot1
|
ras homolog gene family, member T1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
0.8 | 2.4 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.6 | 1.7 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.5 | 1.5 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 0.8 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.4 | 2.7 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 1.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 2.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 1.6 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.3 | 0.8 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.3 | 1.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.6 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) axonogenesis involved in innervation(GO:0060385) |
0.3 | 1.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 1.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 1.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 1.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 1.7 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 1.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 2.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 0.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 3.7 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.2 | 0.6 | GO:1901355 | response to rapamycin(GO:1901355) |
0.2 | 0.6 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.2 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 2.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 0.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.2 | 1.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.7 | GO:0032847 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) regulation of cellular pH reduction(GO:0032847) regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 1.0 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.2 | 0.3 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) ganglion morphogenesis(GO:0061552) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) |
0.2 | 0.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.2 | 2.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.5 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.1 | 0.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.7 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.6 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.5 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 0.4 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 0.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 2.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) distal tubule development(GO:0072017) |
0.1 | 0.2 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 1.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.8 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.8 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 1.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.7 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 1.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.9 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.3 | GO:0060872 | semicircular canal development(GO:0060872) |
0.1 | 0.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.2 | GO:1901254 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
0.1 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.1 | GO:0060849 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.1 | 1.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.6 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.2 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 0.4 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.1 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.8 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 0.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.5 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.2 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.0 | 0.1 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.0 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.0 | 0.0 | GO:0061227 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) ureter urothelium development(GO:0072190) |
0.0 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0033128 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.0 | 1.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.0 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 1.7 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.3 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.0 | 0.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 1.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.4 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.2 | GO:1901580 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.0 | 0.2 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.0 | 0.2 | GO:1902167 | cerebrospinal fluid secretion(GO:0033326) positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.0 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.5 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.1 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 1.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 1.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.1 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
0.0 | 1.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 2.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 1.4 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.3 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.8 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.3 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 2.8 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.2 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.0 | 0.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.3 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 2.1 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.0 | 1.7 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.0 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.2 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.1 | GO:1904637 | cellular response to ether(GO:0071362) response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.0 | 0.2 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.0 | 0.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 0.3 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.0 | 0.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.1 | GO:0090537 | CERF complex(GO:0090537) |
0.5 | 3.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.4 | 1.5 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
0.3 | 1.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 0.8 | GO:0043512 | inhibin A complex(GO:0043512) |
0.3 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 0.8 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.5 | GO:0071920 | cleavage body(GO:0071920) |
0.2 | 0.5 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 1.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 1.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.1 | GO:0070578 | micro-ribonucleoprotein complex(GO:0035068) RISC-loading complex(GO:0070578) |
0.1 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.5 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 2.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 3.5 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 1.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.2 | GO:0019034 | viral replication complex(GO:0019034) dendritic filopodium(GO:1902737) |
0.1 | 0.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.3 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.0 | 0.2 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.0 | 0.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.0 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 1.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 2.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 8.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 2.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 1.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 1.7 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 0.8 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 0.6 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.2 | 0.8 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 1.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.5 | GO:0001132 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.2 | 2.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 1.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.5 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 1.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.5 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 2.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.5 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 1.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 1.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 1.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.2 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.1 | 3.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 2.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.9 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.2 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.0 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.3 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.0 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.9 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) U6 snRNA 3'-end binding(GO:0030629) |
0.0 | 2.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 1.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 1.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.0 | 0.1 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.0 | 1.0 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 2.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.0 | 1.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 2.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 1.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 5.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 8.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.0 | 0.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 1.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.4 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 2.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 2.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 2.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 3.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 3.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 3.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 1.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 3.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.5 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 1.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |